Clinical Outcomes Of Multi-ligament Knee Injuries In Assiut University Hospitals
- Disease/Condition
- Knee Injuries
- Drug/Device/Intervention
- multi-ligament knee surgery
- Study type
- Interventional
- Intervention type
- procedure
- Primary sponsor
- Assiut University
- Location
- Assiut, Egypt
- Phase
- N/A
- Start date
- Jan 01, 2021
- End date
- Dec 01, 2023
- Enrollment
- 4 participants
The arabic translated and validated Lysholm Knee Score
Multi-ligament knee injuries (MLKI) are devastating injuries. They are defined as injuries to
 at least two of the four major ligaments in the knee: anterior cruciate ligament, posterior
 cruciate ligament, lateral collateral ligament (and posterolateral corner) and medial
 collateral ligament (and posteromedial corner). These injuries are commonly classified using
 the Schenck classification system. The incidence of these injuries has been reported to be
 around 0.02-0.20% of all orthopaedic injuries. However, this is likely to be an
 underestimation due to spontaneous knee reduction and missed injuries. The immediate
 management of these injuries is crucial in identifying and treating any vascular and nerve
 injury. The literature has shown poor outcome and residual instability in those who were
 treated non-operatively. However, the optimal surgical treatment for these injuries is not
 known, with differences in opinion amongst treating clinicians. There are controversies in
 the timing of surgery (early versus delayed), single-staged or two-staged procedures and
 whether the damaged ligaments should be repaired or reconstructed
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT04709133
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT04709133 through Pure Global AI's free database. This phase not specified trial is sponsored by Assiut University and is currently Not yet recruiting. The study focuses on Knee Injuries. Target enrollment is 4 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.